Medtech Alert’s Post

View organization page for Medtech Alert, graphic
Medtech Alert

5,886 followers

Direct Biologics Receives FDA Clearance to Initiate Phase 1b/2a Clinical Trial of ExoFlo™ in Patients with Medically Refractory Perianal Fistulizing Crohn’s Disease Amy Lightner Stephen Leider Joe Schmidt Aline “Ali” Betancourt John Vacalis Christian Guth https://lnkd.in/g3c2ptdm #PharmTech #PharmaceuticalNews #Analysis #Data #Investment #DrugDiscovery #COVID19 #Regulation #Mergers #WhosWho #Pharma #healthtech #medtech

Direct Biologics Receives FDA Clearance to Initiate Phase 1b/2a Clinical Trial of ExoFlo™ in Patients with Medically Refractory Perianal Fistulizing Crohn’s Disease

Direct Biologics Receives FDA Clearance to Initiate Phase 1b/2a Clinical Trial of ExoFlo™ in Patients with Medically Refractory Perianal Fistulizing Crohn’s Disease

https://medtechalert.com

Elaine Rihn

Director Business Development CGT

1y

That’s awesome Ali. Would love to catch up at iPSC in Boston this week.

Like
Reply

To view or add a comment, sign in

Medtech Alert

5,886 followers

View Profile

Explore topics